OKYO Pharma received $1.9 million in non-dilutive funding to advance urcosimod for neuropathic corneal pain. This funding aids in clinical development and demonstrates the company's commitment to innovative solutions.
Amount Raised
$1.9 Million
Round Type
Seed
LondonBiotechnologyHealth CareDescription
OKYO Pharma Limited announced it has received $1.9 million in non-dilutive funding to support its research and development programs. The funds will accelerate the clinical development of urcosimod, the company's lead drug candidate. This capital strengthens OKYO Pharma's ability to innovate without affecting shareholder equity.
Quick answer
OKYO Pharma raised $1.9 Million in a Seed round, dated July 17, 2025. OKYO Pharma is based in London, England, United Kingdom.
- How much did OKYO Pharma raise?
- OKYO Pharma raised $1.9 Million in a Seed round on July 17, 2025.
- What does OKYO Pharma do?
- OKYO Pharma is a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an FDA approved therapy, and for..
- Where is OKYO Pharma based and how big is it?
- OKYO Pharma is based in London, England, United Kingdom.
- Who are the decision-makers at OKYO Pharma?
- Fundz holds 1 contact at OKYO Pharma, including the Chief Scientific Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as OKYO Pharma that raised within 45 days of this round, from Fundz verified event records.
- Enlaza Therapeutics raised $15M on August 29, 2025.
- Modus Therapeutics raised $3M (Funding Round) on August 28, 2025.
- Seluna raised $874K (Funding Round) on August 28, 2025.
- PainTEQ raised an undisclosed amount (Funding Round) on August 27, 2025.
- Leal Therapeutics raised $30M (Series A) on August 27, 2025.
- Moonrise Medical raised $396K on August 27, 2025.
Who to call at OKYO Pharma, and when
A new round usually means OKYO Pharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day OKYO Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OKYO Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OKYO Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OKYO Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
OKYO Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.